Back

Gut

17 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Novel adenoma-immune phenotypes are associated with risk of metachronous polyps and colorectal cancer in a bowel screening cohort
2026-02-27 gastroenterology 10.64898/2026.02.25.26346992
#1 (16.6%)
Show abstract

BackgroundCurrent British Society of Gastroenterology (BSG) guidelines misclassify metachronous lesion risk after polypectomy in approximately 40% of patients. Building on evidence that immune exclusion drives progression of adenomas to colorectal cancer, this study examined immune profiles in screen-detected adenomas as a predictive biomarker for metachronous lesion risk. MethodsPatients undergoing polypectomy within the Scottish Bowel Screening Programme, with surveillance colonoscopy between...

2
Comparative Effectiveness and Cardiovascular Outcomes of Infliximab reference product and Biosimilars in Patients with Inflammatory Bowel Disease
2026-01-27 gastroenterology 10.64898/2026.01.25.26344807
#1 (11.5%)
Show abstract

BackgroundAnti-tumor necrosis factor (anti-TNF), particularly infliximab, have transformed inflammatory bowel disease (IBD) management, but their high cost imposes a significant economic burden. Infliximab biosimilars were introduced to reduce the unmet needs. Despite the approval of infliximab biosimilars, real-world evidence of cardiovascular safety and effectiveness of infliximab biosimilars is lacking among patients with IBD. In this trial emulation, we compared the effectiveness and cardiov...

3
Type 1 Dolichocolon as a Potential Anatomic Co-Morbidity in Pediatric Perianal Crohn Disease
2025-12-15 gastroenterology 10.64898/2025.12.10.25341790
#1 (9.2%)
Show abstract

BackgroundPerianal Crohns disease (PCD) represents one of the most severe and refractory forms of pediatric inflammatory bowel disease (IBD). Constipation and colonic redundancy, particularly type 1 dolichocolon (T1-DC), may increase distal rectosigmoid pressure, and exacerbate perianal pathology. We hypothesized that T1-DC is more common in children with PCD than in those with uncomplicated ileocolonic Crohns disease (CD) or non-IBD controls. MethodsWe retrospectively analyzed 20 consecutive p...

4
Opportunistic Upper Endoscopy at the Time of Screening Colonoscopy: Feasibility, Acceptability, and Patient Perspectives
2026-01-27 gastroenterology 10.64898/2026.01.26.26344849
#1 (9.2%)
Show abstract

ObjectivesGastric cancer (GC) is a leading cause of cancer mortality in the United States (U.S.), yet no routine screening strategy exists. Opportunistic upper endoscopy (EGD) performed during screening colonoscopy (EGD-SC) may provide a practical early detection approach. We evaluated the feasibility, acceptability, patient perspectives, and diagnostic yield of EGD-SC. MethodsThis single-center, open-label, single-arm prospective trial enrolled adults aged 45-80 years scheduled for colonoscopy...

5
Anti-inflammatory effects of 12-HHT via epithelial barrier enhancement in colon organoids of normoganglionosis in Hirschsprungs disease
2026-02-19 gastroenterology 10.64898/2026.02.18.26346528
#1 (9.2%)
Show abstract

PurposeHirschsprung-associated enterocolitis remains a major postoperative complication of Hirschsprungs disease (HD), and impaired epithelial barrier integrity has been proposed as a contributing factor. In this study, we investigated whether 12-hydroxyheptadecatrienoic acid (12-HHT), an endogenous leukotriene B4 receptor 2 (BLT-2) agonist, enhances the epithelial barrier and exerts anti-inflammatory effects in patient-derived colonic organoids. MethodsNormoganglionic specimens from rectal/rec...

6
Predicting 7-Day Re-Bleeding after Peptic Ulcer Hemostasis: Retrospective Analysis of Forrest, Complete Rockall, and Glasgow-Blatchford Scores and Independent Risk Factors
2025-12-13 gastroenterology 10.64898/2025.12.10.25342008
#1 (8.6%)
Show abstract

ObjectiveTo identify independent risk factors for early ([≤]7-day) re-bleeding after peptic ulcer bleeding (PUB) and to compare the predictive performance of Forrest classification, Complete Rockall Score (CRS), and Glasgow-Blatchford Score (GBS). MethodsWe retrospectively analyzed adults with endoscopy-confirmed peptic ulcer bleeding from 2015-2020. Early re-bleeding was defined as [≤]7 days after index hemostasis. We applied univariable and multivariable logistic regression and assessed...

7
A distinct serum metabolic signature outperforms C-reactive protein as a non-invasive marker for monitoring disease activity in Inflammatory Bowel Disease
2025-12-11 gastroenterology 10.64898/2025.12.10.25341951
#1 (8.2%)
Show abstract

BackgroundAchieving deep remission, such as e.g. histo-endoscopic remission, is a key objective in inflammatory bowel disease (IBD). However, this metric depends on invasive procedures that are impractical in routine care, whereas current non-invasive blood biomarkers demonstrate only limited correlation with disease activity. ObjectiveWe used serum metabolomics to identify blood-based signatures that comprehensively assess disease activity. DesignSerum was collected from HC (n=195), UC (n=183...

8
Unveiling the Porphyromonadaceae-TFF1 Interaction and ITGAM as Critical Factors in Post-operative Recurrence of Crohn's Disease
2026-01-19 gastroenterology 10.64898/2026.01.16.26344277
Top 0.1% (7.8%)
Show abstract

BackgroundCrohns disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by high post-operative recurrence (POR) rates, reaching up to 90% within one year. Current clinical and endoscopic predictors show limited accuracy. ObjectiveThis study aimed to identify molecular mechanisms associated with POR at the time of surgery through integrated transcriptomic and bacteriomic analyses of ileal tissue. DesignIleal samples were obtained during surgery from 20 patie...

9
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
2025-12-31 gastroenterology 10.64898/2025.12.23.25342823
Top 0.2% (7.3%)
Show abstract

Hereditary -tryptasemia (HT), defined by increased TPSAB1 copy number and elevated basal serum tryptase, is associated with mast cell (MC)-mediated symptoms, yet its role in gastrointestinal disease remains unclear. Because intestinal MCs express the non-IgE-dependent activation receptor MRGPRX2, we investigated whether MRGPRX2 expression is altered in individuals with HT and inflammatory bowel disease (IBD). We genotyped 854 biobanked IBD samples, performed spatial transcriptomics on descending...

10
Potassium-competitive acid channel blockers versus Proton-Pump inhibitors in the prevention of post-endoscopic peptic ulcer rebleeding: A systematic review and meta-analysis
2026-03-06 gastroenterology 10.64898/2026.03.02.26346403
Top 0.2% (6.6%)
Show abstract

Introduction Vonoprazan, a new oral potassium-competitive acid blocker (PCAB), has shown promise in terms of superior acid suppression when compared to Proton pump inhibitors (PPIs). We evaluated the efficacy of PCABs versus PPIs in preventing rebleeding in high-risk peptic ulcer patients after endoscopic hemostasis. Methods Following the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines, we conducted a comprehensive search for relevant studies across Medline...

11
Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): Consensus on Obesity and Cardiometabolic Comorbidities in Inflammatory Bowel Disease using Evidence Synthesis and the RAND/UCLA Appropriateness Method
2025-12-22 gastroenterology 10.64898/2025.12.20.25342738
Top 0.3% (6.6%)
Show abstract

IntroductionObesity and related cardiometabolic comorbidities, including hypertension, dyslipidemia, diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and atherosclerotic cardiovascular disease (ASCVD), are increasingly prevalent among individuals with inflammatory bowel disease (IBD). These conditions influence disease activity, therapeutic response, surgical outcomes, and overall quality of life, yet evidence remains fragmented. The Modulate Obesity and relateD metabo...

12
Decoding WNT Pathway Dysregulation in Bevacizumab-Treated Early-Onset Colorectal Cancer to Inform Precision Oncology
2025-12-23 gastroenterology 10.64898/2025.12.22.25342868
Top 0.3% (6.6%)
Show abstract

Early-onset colorectal cancer (EOCRC) is rising most rapidly among Hispanic/Latino (H/L) populations, yet the prognostic relevance of WNT pathway alterations under contemporary therapies remains unclear. We conducted a multi-cohort analysis integrating somatic genomics with clinical and treatment annotations (including bevacizumab exposure) from public CRC datasets, stratifying by age of onset and ancestry (H/L vs. non-Hispanic White [NHW]). WNT alterations, dominated by APC, were ubiquitous, bu...

13
A Multi-Mineral Intervention Improves Intestinal Permeability in Patients with Ulcerative Colitis: Results from a 90-Day Pilot Trial
2026-01-30 gastroenterology 10.64898/2026.01.28.26345064
Top 0.3% (6.6%)
Show abstract

IntroductionPrevious studies have shown that Aquamin(R), a multi-mineral extract from red marine algae, enhances barrier integrity proteins in the human colon. These findings prompted further investigation into Aquamin(R)s effects on gastrointestinal barrier function and permeability. MethodsSubjects with mild or in remission ulcerative colitis (UC) and healthy controls were enrolled in an open-label trial and received Aquamin(R) capsules (800 mg calcium/day) for 90 days. Intestinal permeabilit...

14
Improving operative outcomes in patients with stomas
2026-01-06 gastroenterology 10.64898/2026.01.05.26343439
Top 0.3% (6.5%)
Show abstract

Stoma formation diverts the flow of faeces to an opening on the skin, away from a section of bowel. Stomas are used to reduce the risks of bowel surgery and their effects are thought to be temporary and benign. However, negative effects [e.g. diversion colitis (inflammation in the excluded segment), poor quality of life, and an unclear effect on homeostasis] occur. We investigated these changes and whether distal feeding (DF) - the introduction of nutrition directly into the defunctioned bowel p...

15
Modified Endoscopic Mucosal Resection Outperforms Endoscopic Submucosal Dissection for Rectal Neuroendocrine Tumors <=10 mm: A Systematic Review and Meta Analysis
2026-02-11 gastroenterology 10.64898/2026.02.10.26345872
Top 0.3% (6.5%)
Show abstract

BackgroundEndoscopic resection is the standard treatment for rectal neuroendocrine tumors (r-NETs) [&le;]10 mm, yet the optimal technique remains controversial. Modified endoscopic mucosal resection (m-EMR) has emerged as a potential alternative compared to endoscopic submucosal dissection (ESD), but existing evidence is largely retrospective and the results of recent randomized controlled trials (RCTs) are inconclusive. AimsTo compare the efficacy and safety of m-EMR versus ESD for r-NETs [&le...

16
Gestational Environment Captured by the Neonatal Metabolome is not Predictive of Later Inflammatory Bowel Disease
2026-02-18 gastroenterology 10.64898/2026.02.18.26346468
Top 0.3% (6.5%)
Show abstract

BackgroundGestational exposures may contribute to the newborns lifetime risk of inflammatory bowel disease (IBD). While gestational influences are associated with IBD onset, the causality and confounding of such exposures are difficult to ascertain. The neonatal metabolome provides a metabolic snapshot of gestational influences. ObjectiveWe tested the neonatal metabolomes ability to predict future IBD, to assess whether gestational exposures are reflected in early molecular precursors of the di...

17
Prevalence and pre-disposing factors of helicobacter pylori among patients with gastro-intestinal symptoms attending Mulago Hospital, Kampala, Uganda
2026-02-24 gastroenterology 10.64898/2026.02.23.26346905
Top 0.4% (6.4%)
Show abstract

BackgroundComprehensive data on the prevalence of Helicobacter pylori infection and its associated risk factors among patients with gastrointestinal symptoms remain limited. Generating this evidence would help inform clinical management and improve antibiotic stewardship. H. pylori infection affects a substantial proportion of the global population, with prevalence varying widely across regions. In Uganda, previous studies have documented the presence of H. pylori infection. However, data specif...

18
Distinct Gastrointestinal Symptom Phenotypes in Adults with Cystic Fibrosis are linked to complications and medication use
2026-01-21 gastroenterology 10.64898/2026.01.16.26344251
Top 0.4% (6.3%)
Show abstract

Background and aimsGastrointestinal symptoms remain common in adults with cystic fibrosis (CF) despite cystic fibrosis transmembrane conductance regulator modulator use, suggesting persistent and heterogeneous gut dysfunction. This prospective observational study tests the hypothesis that distinct gut symptom phenotypes in CF can be observed and linked to underlying mechanisms. MethodsAdults from three UK CF centres completed the Gastrointestinal Symptom Rating Scale, Patient Assessment of Cons...

19
Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with Metabolically Dysfunction Associated Steatotic Liver Disease
2026-01-11 gastroenterology 10.64898/2026.01.08.26343687
Top 0.4% (6.3%)
Show abstract

Introduction and ObjectivesMetabolic dysfunction-associated steatotic liver disease (MASLD) affects about one-quarter of adults worldwide, and liver fibrosis is its strongest predictor of liver-related morbidity and mortality. Using combined in-silico screening and clinical validation, we aimed to identify circulating biomarkers associated with fibrosis progression. Fibulin-3 was identified, and its diagnostic performance was evaluated in biopsy-proven MASLD cohorts. Materials and MethodsThe GS...

20
Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies eight novel risk genes including MYC, MAP3K9, DHRS1, and MTTP
2025-12-17 gastroenterology 10.64898/2025.12.16.25342341
Top 0.4% (6.3%)
Show abstract

Background & AimsHepatocellular carcinoma (HCC) is the third top cause of cancer death globally, often arising on a background of cirrhosis. Here, we aimed to establish novel genetic drivers of HCC across ancestries at a population level through a large meta-analysis of all-cause HCC. Approach & ResultsWe included 15 cohorts comprising 17,329 HCC cases and 2,424,298 controls in this meta-analysis. We found 15 genome-wide significant (P < 5x10-8) germline loci, 6 novel in/near GCKR, MTTP, ADH5, ...